Estrogen Receptor Modulators Global Market Report 2025
상품코드:1764309
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
에스트로겐 수용체 조절제 시장 규모는 향후 몇 년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 성장은 차세대 SERM의 파이프라인 확대, 종양학 연구 및 개발에 대한 투자 증가, 호르몬에 민감한 암의 유병률 증가, 맞춤형 의약품의 광범위한 채택, 새로운 에스트로겐 수용체 조절제의 승인 전망에 기인할 수 있습니다. 이 기간 동안의 주요 동향으로는 선택적 에스트로겐 수용체 분해제(SERD)의 발전, 조직 선택적 조절제의 개발, 병용 요법 접근법의 혁신, 바이오마커 기반 의약품 타겟팅의 발전, 안전성 프로파일이 개선된 경구용 SERM의 개발 등이 있습니다.
유방암의 유병률 증가는 향후 에스트로겐 수용체 조절제 시장의 성장을 촉진할 것으로 예상됩니다. 유방암은 유방에 비정상적인 세포가 통제할 수 없이 증식하여 주변 조직을 침범하거나 신체의 다른 부위로 전이될 수 있는 종양을 형성하는 질환입니다. 유방암 발병률의 증가는 출산 연령이 늦어짐에 따라 호르몬 수치가 변화하고 일생 동안 에스트로겐에 노출되는 시간이 증가하여 암 발병 위험이 높아지기 때문으로 보입니다. 에스트로겐 수용체 조절제는 에스트로겐의 암 세포에 대한 영향을 차단하거나 조절하여 세포 성장 속도를 늦추고 질병 진행 또는 재발 위험을 감소시키는 데 핵심적인 역할을 합니다. 예를 들어, 2025년 2월 미국 기반 국제기구인 유엔은 2022년 전 세계에서 유방암이 약 230만 건의 신규 사례와 67만 명의 사망을 차지했다고 보고했습니다. 2050년까지 전 세계적으로 신규 발병 건수가 38% 증가하고 연간 사망자가 68% 증가할 것으로 예상되어 이 질병의 영향력이 커지고 있습니다. 따라서 유방암의 발병률이 증가하면서 에스트로겐 수용체 조절제 시장이 성장하고 있습니다.
에스트로겐 수용체 조절제 시장 주요 기업들은 폐경 증상 완화(예: 열감)를 효과적으로 완화하면서 호르몬 관련 암 및 심혈관 질환 위험을 최소화하는 혁신적인 치료법 개발에 집중하고 있습니다. 에스트로겐 기반 폐경 호르몬 치료는 에스트로겐 단독 또는 프로게스틴과 결합하여 폐경 관련 증상을 완화하기 위해 투여됩니다. 예를 들어, 2023년 6월 미국 기반 제약 및 바이오기술 기업인 Pfizer Inc.는 업데이트된 포장 디자인으로 DUAVEE(결합 에스트로겐/바제도시펜)를 재출시했습니다. 이 호르몬 요법은 자궁을 가진 폐경 후 여성들을 대상으로 하며, 결합형 에스트로겐과 선택적 에스트로겐 수용체 조절제(SERM)인 바제도시펜을 결합합니다. 이는 자궁 내막 두꺼워짐 위험을 낮춤으로써 전통적인 에스트로겐-프로게스틴 치료법의 대안을 제공합니다. DUAVEE는 하루에 한 번 경구용 정제로 복용되며, 증상 관리에 필요한 최소 기간 동안 사용하도록 권장됩니다. 일반적인 부작용으로는 근육 경련, 메스꺼움, 위장 불편감이 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 에스트로겐 수용체 조절제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 에스트로겐 수용체 조절제 시장 : 성장률 분석
세계의 에스트로겐 수용체 조절제 시장 실적 : 규모와 성장(2019-2024년)
세계의 에스트로겐 수용체 조절제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 에스트로겐 수용체 조절제 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 에스트로겐 수용체 조절제 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
선택적 에스트로겐 수용체 조절제
비선택적 에스트로겐 수용체 조절제
선택적 에스트로겐 수용체 하향 조절제(SERD)
세계의 에스트로겐 수용체 조절제 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
주사
국소
세계의 에스트로겐 수용체 조절제 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
유방암 치료
골다공증 치료
불임치료
호르몬 보충 요법(HRT)
세계의 에스트로겐 수용체 조절제 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
온라인 약국
소매 약국
세계의 에스트로겐 수용체 조절제 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
홈케어
전문센터
기타 최종 사용자
세계의 에스트로겐 수용체 조절제 시장 : 선택적 에스트로겐 수용체 조절제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
타목시펜
라록시펜
트레미펜
바제독시펜
라소폭시펜
세계의 에스트로겐 수용체 조절제 시장 : 비선택적 에스트로겐 수용체 조절제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
크로미펜
디에틸스틸 베스트롤(DES)
기타 비선택적 조절제
세계의 에스트로겐 수용체 조절제 시장 : 선택적 에스트로겐 수용체 하향 조절제(SERD) 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
풀 베스트 런트
엘라세스트란트
OP-1250(치험약)
기타 구강 SERD
제7장 지역별, 국가별 분석
세계의 에스트로겐 수용체 조절제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 에스트로겐 수용체 조절제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
에스트로겐 수용체 조절제 시장 : 경쟁 구도
에스트로겐 수용체 조절제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson : 개요, 제품 및 서비스, 전략 및 재무 분석
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bayer AG
Sanofi SA
AstraZeneca PLC
Novartis AG
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Apotex Inc
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Aurobindo Pharma
Alkem Laboratories Ltd.
Atossa Therapeutics
Ligand Pharmaceuticals
Panacea Biotec
Sermonix Pharmaceuticals Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
에스트로겐 수용체 조절제 시장(2029년) : 새로운 기회를 제공하는 국가
에스트로겐 수용체 조절제 시장(2029년) : 새로운 기회를 제공하는 부문
에스트로겐 수용체 조절제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Estrogen receptor modulators are drugs that attach to estrogen receptors and either mimic estrogen's effects (agonists) or inhibit estrogen activity (antagonists), depending on the specific tissue targeted. This selective action enables their use in treating various hormone-related conditions such as breast cancer, osteoporosis, and menopausal symptoms, providing estrogen's benefits in certain tissues while reducing associated risks in others.
The primary types of estrogen receptor modulators include selective estrogen receptor modulators (SERMs), non-selective estrogen receptor modulators, and selective estrogen receptor down regulators (SERDs). SERMs are compounds that bind to estrogen receptors across different tissues, acting as either agonists or antagonists based on the tissue involved. They can be administered orally, by injection, or topically, and are used in treatments for breast cancer, osteoporosis, infertility, and hormone replacement therapy (HRT). These modulators are distributed via hospital pharmacies, online pharmacies, and retail pharmacies, serving end users such as home care providers, specialty centers, and others.
The estrogen receptor modulators market research report is one of a series of new reports from The Business Research Company that provides estrogen receptor modulators market statistics, including estrogen receptor modulators industry global market size, regional shares, competitors with an estrogen receptor modulators market share, detailed estrogen receptor modulators market segments, market trends and opportunities, and any further data you may need to thrive in the estrogen receptor modulators industry. This estrogen receptor modulators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The estrogen receptor modulators market size has grown strongly in recent years. It will grow from $15.73 billion in 2024 to $17.12 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the rising demand for targeted cancer therapies, increased research on selective estrogen receptor modulators (SERMs), a growing number of clinical trials for estrogen-related conditions, and expanding uses in male health disorders.
The estrogen receptor modulators market size is expected to see strong growth in the next few years. It will grow to $23.68 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth anticipated in the forecast period can be attributed to the expanding pipeline of next-generation SERMs, increased investment in oncology research and development, rising prevalence of hormone-sensitive cancers, broader adoption in personalized medicine, and the expected approval of novel estrogen receptor modulators. Key trends during this period include advancements in selective estrogen receptor degraders (SERDs), development of tissue-selective modulators, innovations in combination therapy approaches, progress in biomarker-based drug targeting, and the creation of oral SERMs with enhanced safety profiles.
The increasing prevalence of breast cancer is expected to drive the growth of the estrogen receptor modulators market in the future. Breast cancer is a condition where abnormal cells in the breast grow uncontrollably, forming tumors that can invade surrounding tissues or spread to other areas of the body. The rise in breast cancer cases is linked to more women delaying childbirth, which alters hormone levels and increases lifetime estrogen exposure, thereby elevating cancer risk. Estrogen receptor modulators play a key role in managing breast cancer by blocking or modifying estrogen's effects on cancer cells, slowing their growth, and reducing the risk of disease progression or recurrence. For example, in February 2025, the United Nations, a US-based intergovernmental organization, reported that in 2022, breast cancer accounted for around 2.3 million new cases and 670,000 deaths worldwide. By 2050, global estimates predict a 38% increase in new cases and a 68% rise in annual deaths, underscoring the growing impact of the disease. Hence, the rising prevalence of breast cancer is propelling the estrogen receptor modulators market forward.
Leading companies in the estrogen receptor modulators market are concentrating on developing innovative treatments, such as estrogen-based menopause hormone therapy, to effectively alleviate menopausal symptoms like hot flashes while minimizing risks associated with hormone-related cancers and cardiovascular issues. Estrogen-based menopause hormone therapy involves administering estrogen alone or combined with progestin to ease menopause-related symptoms. For example, in June 2023, Pfizer Inc., a US-based pharmaceutical and biotechnology firm, reintroduced DUAVEE (conjugated estrogens/bazedoxifene) with updated packaging. This hormone therapy targets postmenopausal women with a uterus and combines conjugated estrogens with bazedoxifene, a selective estrogen receptor modulator. It offers an alternative to conventional estrogen-progestin treatments by lowering the risk of uterine lining thickening. DUAVEE is administered once daily as an oral tablet and is advised for the shortest period necessary to manage symptoms. Common side effects include muscle spasms, nausea, and stomach discomfort.
In April 2024, Atossa Therapeutics, a US-based clinical-stage biopharmaceutical company specializing in selective estrogen receptor modulators (SERMs) for various breast cancer treatments, partnered with Weill Cornell Medicine to explore the potential synergy between antibody-drug conjugates (ADCs) and (Z)-endoxifen. This collaboration aims to assess and confirm the effectiveness of combining (Z)-endoxifen with ADCs to develop improved combination therapies for advanced and metastatic breast cancer. Weill Cornell Medicine, a US-based academic medical institution, is recognized for its leading research in oncology and other therapeutic fields.
Major players in the estrogen receptor modulators market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca PLC, Novartis AG, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Aurobindo Pharma, Alkem Laboratories Ltd., Atossa Therapeutics, Ligand Pharmaceuticals, Panacea Biotec, Sermonix Pharmaceuticals Inc., MSN Laboratories, Deus Medical.
North America was the largest region in the estrogen receptor modulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in estrogen receptor modulators report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the estrogen receptor modulators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The estrogen receptor modulators market consists of sales of products, including selective estrogen receptor modulators (SERMs), estrogen receptor antagonists, estrogen receptor agonists, and combination hormonal therapies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Estrogen Receptor Modulators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on estrogen receptor modulators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for estrogen receptor modulators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The estrogen receptor modulators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Estrogen Receptor Modulators Market Trends And Strategies
4. Estrogen Receptor Modulators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Estrogen Receptor Modulators Growth Analysis And Strategic Analysis Framework
5.1. Global Estrogen Receptor Modulators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Estrogen Receptor Modulators Market Growth Rate Analysis
5.4. Global Estrogen Receptor Modulators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Estrogen Receptor Modulators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Estrogen Receptor Modulators Total Addressable Market (TAM)
6.2. Global Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
6.3. Global Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer Treatment
Osteoporosis Treatment
Infertility Treatment
Hormone Replacement Therapy (HRT)
6.4. Global Estrogen Receptor Modulators Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
6.5. Global Estrogen Receptor Modulators Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Speciality Centres
Other End Users
6.6. Global Estrogen Receptor Modulators Market, Sub-Segmentation Of Select Estrogen Receptor Modulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tamoxifen
Raloxifene
Toremifene
Bazedoxifene
Lasofoxifene
6.7. Global Estrogen Receptor Modulators Market, Sub-Segmentation Of Non-Selective Estrogen Receptor Modulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clomiphene
Diethylstilbestrol (DES)
Other Non-Selective Modulators
6.8. Global Estrogen Receptor Modulators Market, Sub-Segmentation Of Selective Estrogen Receptor Downregulators (SERDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fulvestrant
Elacestrant
OP-1250 (Investigational)
Other Oral SERDs
7. Estrogen Receptor Modulators Market Regional And Country Analysis
7.1. Global Estrogen Receptor Modulators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Estrogen Receptor Modulators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Estrogen Receptor Modulators Market
9.1. China Estrogen Receptor Modulators Market Overview
9.2. China Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Estrogen Receptor Modulators Market
10.1. India Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Estrogen Receptor Modulators Market
11.1. Japan Estrogen Receptor Modulators Market Overview
11.2. Japan Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Estrogen Receptor Modulators Market
12.1. Australia Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Estrogen Receptor Modulators Market
13.1. Indonesia Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Estrogen Receptor Modulators Market
14.1. South Korea Estrogen Receptor Modulators Market Overview
14.2. South Korea Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Estrogen Receptor Modulators Market
15.1. Western Europe Estrogen Receptor Modulators Market Overview
15.2. Western Europe Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Estrogen Receptor Modulators Market
16.1. UK Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Estrogen Receptor Modulators Market
17.1. Germany Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Estrogen Receptor Modulators Market
18.1. France Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Estrogen Receptor Modulators Market
19.1. Italy Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Estrogen Receptor Modulators Market
20.1. Spain Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Estrogen Receptor Modulators Market
21.1. Eastern Europe Estrogen Receptor Modulators Market Overview
21.2. Eastern Europe Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Estrogen Receptor Modulators Market
22.1. Russia Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Estrogen Receptor Modulators Market
23.1. North America Estrogen Receptor Modulators Market Overview
23.2. North America Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Estrogen Receptor Modulators Market
24.1. USA Estrogen Receptor Modulators Market Overview
24.2. USA Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Estrogen Receptor Modulators Market
26.1. South America Estrogen Receptor Modulators Market Overview
26.2. South America Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Estrogen Receptor Modulators Market
27.1. Brazil Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Estrogen Receptor Modulators Market
28.1. Middle East Estrogen Receptor Modulators Market Overview
28.2. Middle East Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Estrogen Receptor Modulators Market
29.1. Africa Estrogen Receptor Modulators Market Overview
29.2. Africa Estrogen Receptor Modulators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Estrogen Receptor Modulators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Estrogen Receptor Modulators Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Estrogen Receptor Modulators Market Competitive Landscape And Company Profiles
